NHS England director: 'Budget constraint' to blame for hepatitis C drug delays

By Will Hazell2015-07-24T12:53:00

Delays to the introduction of groundbreaking, cost effective hepatitis C drugs have occurred because of ‘budget constraint’, NHS England’s specialised commissioning director has indicated.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
10 expert briefings every fortnight (Premium only)
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

to HSJ

Already a subscriber? Sign into your account here